Results 121 to 130 of about 1,385,207 (269)
Investigating transcription factor dynamics in health and disease using FRAP
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj +3 more
wiley +1 more source
Thymol: properties, synthesis, mechanism of action, and applications. [PDF]
Liu S +13 more
europepmc +1 more source
Conserved binding mode but diverse interfaces of MreC‐PBP2 interactions
The crystal structure of abMreC reveals a conserved two β‐barrel architecture and provides structural insights into its role within the bacterial elongasome. The abMreC–abPBP2 complex model identifies the molecular basis of MreC‐mediated PBP2 recognition, contributing to the regulation of peptidoglycan synthesis.
Hyunseok Jang +4 more
wiley +1 more source
Mechanism of action of Houttuynia cordata extract and its application in animal production. [PDF]
Xu D +14 more
europepmc +1 more source
On the Mechanism of Action of Encephabol
openaire +2 more sources
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source
The expression and mechanism of action of ADAMTS18 in endometrial cancer. [PDF]
Li X, Xu M, Guo X, Xu Y.
europepmc +1 more source
Mechanism of transaminase action [PDF]
T, OSHIMA, N, TAMIYA
openaire +3 more sources
Although too much iron in the brain promotes neurodegeneration, iron ion chelators have had mixed effects in clinical trials. This review explains why; some chelators do not render the iron redox‐inactive (e.g., L1) whereas others do (e.g., desferrioxamine).
Barry Halliwell
wiley +1 more source
The major toxins of Bacillus cereus - Current knowledge on distribution, regulation and mechanism of action. [PDF]
Albahri M, Jessberger N.
europepmc +1 more source

